Calendar Celltrion, Inc.

Equities

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 13/02/2026			5-day change	1st Jan Change
238,000.00 ^KRW	-0.21%		-0.63%	+31.49%

02-05	CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists (February 5)	RE
01-30	Celltrion Launches Autoimmune Drug Aptozma in Europe	MT

Chart calendar Celltrion, Inc.

4ff410e60236bd8038889c245.WAfXusMgp-Ax9ajqG0ApKg2GM1cnmsXLq9lpQdL5VYk.PjGOyKxs5tJ9ht6kUHNTHUXvRCZ0442b9K4YApXMZvoVVKCOhW3liHS74Q~b890b91eb26e37522375f9501be2011e

Upcoming events on Celltrion, Inc.

24/03/2026	Annual General Meeting	Add to your calendar Google Apple ICS format
07/05/2026	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
18/08/2026	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
04/11/2026	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
02/03/2027	Q4 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Celltrion, Inc.

04/02/2026	Q4 2025 Earnings Release
13/01/2026	J.P. Morgan Healthcare Conference
13/11/2025	Q3 2025 Earnings Release
20/07/2025	Q2 2025 Earnings Release
08/05/2025	Q1 2025 Earnings Release
06/05/2025	Digestive Disease Week Conference - Poster No.: #0014
04/05/2025	Digestive Disease Week Conference - Poster No.: #0011
04/05/2025	Digestive Disease Week Conference - Poster No.: #0017
04/05/2025	Digestive Disease Week Conference - Poster No.: #0039
04/05/2025	Digestive Disease Week Conference - Poster No.: #0016
04/05/2025	Digestive Disease Week Conference - Poster No.: #0035
24/02/2025	Q4 2024 Earnings Release
27/11/2024	Investor Meeting
07/11/2024	Q3 2024 Earnings Release
13/08/2024	Q2 2024 Earnings Release
08/05/2024	Q1 2024 Earnings Release
28/02/2024	Q4 2023 Earnings Release
09/01/2024	JPMorgan Healthcare Conference
06/11/2023	Q3 2023 Earnings Release
12/09/2023	Roadshow - Day - 2

Past dividends on Celltrion, Inc.

28/12/2025	Other Dividend 750 KRW
26/12/2024	Annual 750 KRW
26/12/2023	Annual 500 KRW
27/12/2022	Annual 375 KRW
28/12/2021	Annual 750 KRW
26/12/2012	Annual 15 KRW
27/12/2011	Annual 100 KRW
28/12/2010	Annual 75 KRW
26/12/2007	Annual 50 KRW

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Billions KRW	Released Forecast Spread	2 284 2 367 -3.53%	2 176 2 369 -8.11%	3 557 3 498 1.68%	4 162 4 141 0.53%	5 219	5 936
EBITDA Billions KRW	Released Forecast Spread	874 981 -10.95%	897 1 024 -12.4%	910 957 -4.88%	0,00 1 480 -	2 059	2 350
EBIT Billions KRW	Released Forecast Spread	647 751 -13.82%	651 836 -22.03%	492 569 -13.59%	1 168 1 152 1.39%	1 714	2 000
Earnings before Tax (EBT) Billions KRW	Released Forecast Spread	626 799 -21.59%	671 834 -19.5%	576 569 1.22%	1 154 1 108 4.16%	1 709	1 978
Net income Billions KRW	Released Forecast Spread	533 622 -14.21%	536 703 -23.81%	423 441 -4.08%	1 030 867 18.81%	1 374	1 586
EPS KRW	Released Forecast Spread	3 530 3 945 -10.52%	3 437 4 442 -22.62%	1 966 1 862 5.59%	0,00 3 766 -	5 949	6 913
Announcement Date		03/03/23	29/02/24	25/02/25	04/02/26

Quarterly results

Fiscal Period	September	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Billions KRW	Released Forecast Spread	737 722 2.1%	875 804 8.84%	882 936 -5.75%	1 064 1 018 4.48%	842 935 -9.96%	961 987 -2.63%	1 026 1 110 -7.59%	1 330 1 262 5.43%	1 127	1 227	1 343	1 526
EBITDA Billions KRW	Released Forecast Spread	147 103 42.76%	205 198 3.28%	283 290 -2.24%	275 282 -2.47%	220 266 -17%	319 310 2.88%	375 366 2.23%	542	412	477	510	585
EBIT Billions KRW	Released Forecast Spread	15,4 7,44 107.41%	72,5 77,0 -5.9%	208 213 -2.41%	196 270 -27.2%	149 204 -26.71%	242 238 1.79%	301 336 -10.28%	475 451 5.46%	347	398	443	510
Earnings before Tax (EBT) Billions KRW	Released Forecast Spread		104 82,6 26.15%	178 208 -14.47%	274 280 -2.13%	195 213 -8.01%	52,4 248 -78.87%	378 370 2.29%	528 506 4.25%	332
Net income Billions KRW	Released Forecast Spread	22,4 7,67 192.67%	78,0 63,8 22.24%	85,6 171 -49.99%	237 219 8.29%	109 154 -29.6%	61,2 194 -68.48%	332 267 24.29%	528 399 32.42%	273	332	395	438
EPS KRW	Released Forecast Spread		345 239 44.62%	379 791 -52.1%	1 102 892 23.47%	509 648 -21.49%	276 880 -68.64%	1 508 1 122 34.43%	1 598	1 331	1 425	1 580	1 859
Announcement Date		09/05/24	07/08/24	08/11/24	25/02/25	09/05/25	20/07/25	20/10/25	04/02/26	-	-	-	-

Upcoming sector events for Celltrion, Inc.

19/02/2026	TELIX PHARMACEUTICALS LIMITED	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
23/02/2026	VIR BIOTECHNOLOGY, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
23/02/2026	FULCRUM THERAPEUTICS, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
24/02/2026	GALAPAGOS NV	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
24/02/2026	TEMPUS AI, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
24/02/2026	ABCELLERA BIOLOGICS INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
24/02/2026	ICON PUBLIC LIMITED COMPANY	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
25/02/2026	ALKERMES PLC	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
25/02/2026	IONIS PHARMACEUTICALS, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
25/02/2026	ARCUS BIOSCIENCES, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format

More events

Past sector events for Celltrion, Inc.

Today	GRAIL, INC.	Q4 2025 Earnings Release
Today	PRAXIS PRECISION MEDICINES, INC.	Q4 2025 Earnings Release
Today	KYMERA THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)
Today	INTELLIA THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)
Today	RELAY THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)
Today	AMICUS THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)
18/02/2026	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	Q4 2025 Earnings Release
18/02/2026	BIOARCTIC AB	Q4 2025 Earnings Release
17/02/2026	IDEAYA BIOSCIENCES, INC.	Q4 2025 Earnings Release
17/02/2026	BASILEA PHARMACEUTICA AG	Q4 2025 Earnings Release